Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02439723
Title Effects of LBM and PPIs on Pharmacokinetics and Safety of Regorafenib (BAY 73-4506) in Cancer Patients
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors AHS Cancer Control Alberta
Indications

Advanced Solid Tumor

Therapies

Regorafenib

Age Groups: adult
Covered Countries CAN


No variant requirements are available.